Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site.... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

3 minutes

Express Scripts (ESRX) 4Q15 Results: Surprise Sales Dip, Soft Outlook

Primary Analyst: Coresight Research
Contributors
Primary Analyst: Coresight Research
Insight Report

Executive Summary

  • Express Scripts reported 4Q15 revenue of $26.2 billion, slightly below the consensus estimate of $26.5 billion and roughly flat compared to the same quarter a year ago.
  • The company reported diluted EPS of $1.56, in line with the consensus estimate of $1.56 and up 12.2% year over year.
  • The company narrowed its EPS guidance for FY16. The company now expects earnings in the range of $6.10–$6.28 versus previous guidance of $6.08–$6.28. The current consensus estimate is for EPS of $6.13. For 1Q16, Express Scripts expects earnings in the range of $1.18–$1.22, below the consensus of $1.28.
You are currently viewing a preview of this report.

Please select an access option to view the full report. Hide Options -

Get unlimited access to all our research with one of our subscription plans.

View Subscription Plans
or

Contact us to purchase this report.

Contact us